Brina Medical LLC proudly launches the CMAT Advantage — a revolutionary next-generation point-of-care diagnostic device engineered to empower hospitals and healthcare providers to outpace the relentless rise of chronic disease. Built for speed, precision, and seamless integration at the frontline, this U.S.-designed and manufactured system leverages proprietary AI and precision-calibrated decision support tools to deliver real-time clinical insights, enabling care teams to detect disease earlier, intervene with confidence, and elevate patient care.
Health Technology Insights: Dr. Ray Kotwicki Named President of Southern Psychiatric Association
“Hospitals and healthcare providers face immense pressure to achieve better outcomes with fewer resources — and that’s exactly where the CMAT Advantage delivers,” said Brent Pearson, CEO of Brina Medical. “Designed for the realities of modern care — high volume, limited time, and maximum stakes — CMAT Advantage gives care teams a powerful ally to detect chronic disease early, act decisively, and improve lives before complications escalate. This isn’t just a diagnostic device — it’s a catalyst for system-wide transformation.”
Health Technology Insights: Qbtech Grows US Operations with New Houston Teams
The CMAT Advantage integrates directly into clinical workflows, enabling providers to pinpoint disease at its most manageable stage, reduce avoidable hospitalizations, accelerate clinical decisions, and expand care capacity — all while restoring vital bandwidth to frontline teams and earning deeper patient trust.
“What sets Brina Medical apart isn’t just innovation — it’s how we empower hospitals and independent healthcare providers to operationalize it,” Pearson added. “From pilots to full-scale rollouts, we collaborate closely with operational leaders to implement the CMAT Advantage where it delivers measurable, immediate, and sustainable impact. We don’t just provide diagnostics — we drive momentum across the entire care continuum.”
Extending Reach with Strategic Leadership
Brina Medical also announces the formation of its Advisory Board — a collective of highly accomplished leaders in healthcare operations, innovation, and governance. This Board will actively shape Brina Medical’s domestic and global growth strategies, ensuring alignment with the evolving needs of hospital systems, provider networks, and value-based care ecosystems.
Health Technology Insights: BlueRidge Life Sciences Appoints Ian Kelly as Chief Executive Officer
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
